---
xps_name: HbA1c
outcome: chd
lag: 4
distribution: lognormal
source: For RRs, we used "Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis https://doi.org/10.1371/journal.pone.0042551 Figure 2. The pooled relative risk associated with a 1% increase in glycosylated hemoglobin level among patients with type 2 diabetes was 1.15 (95% CI, 1.10 to 1.20) for incident CHD (non-fatal myocardial infarction, and fatal CHD)." For the ideal level, we used "Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017 Jul 31;7(7):e015949. doi: 10.1136/bmjopen-2017-015949. our findings establish optimal HbA1c levels, for the lowest all-cause and cardiovascular mortality, ranging from 6.0% to 8.0% in people with diabetes and from 5.0% to 6.0% in those without diabetes."  
notes: The pooled RR were multivariable-adjusted. 
apply_rr_extra_fn: >
  function(sp) {
    if (!inherits(sp, 'SynthPop')) stop('Argument sp needs to be a SynthPop object.')
    sp$pop[, HbA1c_rr := clamp(HbA1c_rr^((HbA1c - self$get_ideal_xps_lvl(sp$mc_aggr)) / 1), 1, 20)]
  }
ideal_xps_lvl_fn: >
  function(design_) { # Based on the cutoff point of HbA1c of 6.5%
    if (!inherits(design_, 'Design')) stop('Argument design needs to be a Design object.')
    save.seed <- get('.Random.seed', .GlobalEnv)
    set.seed(851797L) # Same for stroke, CHD & T2DM
    res <- runif(design_$sim_prm$iteration_n_max, 6, 7)
    assign('.Random.seed', save.seed, .GlobalEnv)
    res
    }
---
agegroup,sex,rr,ci_rr
<1,men,1,1
01-04,men,1,1
05-09,men,1,1
10-14,men,1,1
15-19,men,1,1
20-24,men,1,1
25-29,men,1,1
30-34,men,1.15,1.20
35-39,men,1.15,1.20
40-44,men,1.15,1.20
45-49,men,1.15,1.20
50-54,men,1.15,1.20
55-59,men,1.15,1.20
60-64,men,1.15,1.20
65-69,men,1.15,1.20
70-74,men,1.15,1.20
75-79,men,1.15,1.20
80-84,men,1.15,1.20
85-89,men,1.15,1.20
90-94,men,1.15,1.20
95-99,men,1.15,1.20
<1,women,1,1
01-04,women,1,1
05-09,women,1,1
10-14,women,1,1
15-19,women,1,1
20-24,women,1,1
25-29,women,1,1
30-34,women,1.15,1.20
35-39,women,1.15,1.20
40-44,women,1.15,1.20
45-49,women,1.15,1.20
50-54,women,1.15,1.20
55-59,women,1.15,1.20
60-64,women,1.15,1.20
65-69,women,1.15,1.20
70-74,women,1.15,1.20
75-79,women,1.15,1.20
80-84,women,1.15,1.20
85-89,women,1.15,1.20
90-94,women,1.15,1.20
95-99,women,1.15,1.20
